Flange extender
Latest BRISTOL-MYERS SQUIBB COMPANY Patents:
- Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
- Antibodies Binding to Human PAD4 and Uses Thereof
- Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
- Substituted bicyclic compounds useful as T cell activators
- METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
Description
The broken lines illustrate portions of the drawings that form no part of the claimed design.
Claims
The ornamental design for a flange extender, as shown and described.
Referenced Cited
U.S. Patent Documents
4981476 | January 1, 1991 | Aichlmayr |
D449379 | October 16, 2001 | Fuhr |
D576276 | September 2, 2008 | Osypka |
D581044 | November 18, 2008 | Sudo |
D581045 | November 18, 2008 | Sudo |
D602158 | October 13, 2009 | Cuevas |
D649241 | November 22, 2011 | Kunishige |
D660418 | May 22, 2012 | Kuczek |
D675317 | January 29, 2013 | Baxter |
D702835 | April 15, 2014 | Vinchon |
8887729 | November 18, 2014 | Harrington |
D751705 | March 15, 2016 | Hitscherich, Jr. |
D757258 | May 24, 2016 | WeiβHaupt et al. |
Patent History
Patent number: D802126
Type: Grant
Filed: Feb 2, 2017
Date of Patent: Nov 7, 2017
Assignee: BRISTOL-MYERS SQUIBB COMPANY (Princeton, NJ)
Inventors: Eric Schiller (Westfield, NJ), Christina Joy Laskar (Fort Lee, NJ), Mitali Aon (Martinsville, NJ), Richard Caizza (Union City, NJ), Jon Bell (Waldwick, NJ)
Primary Examiner: David Muller
Application Number: 29/592,766
Type: Grant
Filed: Feb 2, 2017
Date of Patent: Nov 7, 2017
Assignee: BRISTOL-MYERS SQUIBB COMPANY (Princeton, NJ)
Inventors: Eric Schiller (Westfield, NJ), Christina Joy Laskar (Fort Lee, NJ), Mitali Aon (Martinsville, NJ), Richard Caizza (Union City, NJ), Jon Bell (Waldwick, NJ)
Primary Examiner: David Muller
Application Number: 29/592,766
Classifications
Current U.S. Class:
Syringe, Catheter Or Needle Component (22) (D24/130)